Clinical Trials Browser

Peritoneal Neoplasms × avelumab × 1 year × Clear all

NCT03252938 2026-02-19

INSIGHT

Phase 1 Active not recruiting

GenitourinaryGynecologic

Carcinoma, Transitional Cell, Peritoneal Neoplasms